Mayo's Center for Translational Science Activities (CTSA) is pleased to announce a new series of scientific awards called the Novel Methodology Development Award. The development of new methodologies is critical to the advancement of translational and clinical research. Even though Mayo investigators have been actively involved in creating translational research methods, this new competitive and peer-reviewed program will provide a dedicated funding mechanism to accelerate such work. The goal is to facilitate the development of state-of-the-art tools and innovative modifications of existing methods for translational research and to make them rapidly available to clinical investigators.
These awards are to support the development of novel clinical and translational methods and can encompass a wide range of techniques. Examples of areas that fall within the scope of this mechanism include:
Note, however, that the proposed methods should have wide applicability (i.e., not specific to a narrow range of interests or experiments), and they should be ready for dissemination to the clinical research community by the end of the 1-year award period. Specifically, methods whose feasibility is questionable should not be developed via this award, since the emphasis in this mechanism is the development of tools that are immediately practicable.